New Rare Disease Network Launches in Ireland
source: unsplash.com

New Rare Disease Network Launches in Ireland

According to a story from sciencex.com, Queen's University Belfast, University College Dublin, and a team of 33 other partners have come together to start the All-Ireland Rare Disease Interdisciplinary Research…

Continue Reading New Rare Disease Network Launches in Ireland
Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders
source: unsplash.com

Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders

According to a story from World Pharma Today, Andelyn Biosciences, Inc., which is a gene therapy Contract Development and Manufacturing Organization (CDMO), has recently struck a partnership with Odylia Therapeutics,…

Continue Reading Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders
Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa
source: unsplash.com

Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa

According to a story from VICE News, Congressman George Santos was recently elected to Congress in the 2022 mid-term elections. Since then, his past has been placed under scrutiny, and…

Continue Reading Congressman George Santos Apparently Lied About Helping Kids Living with Epidermolysis Bullosa
6th Annual Zebra Run Raised Support, Funds, and Awareness for Multiple Sulfatase Deficiency (MSD) 
source: pixabay.com

6th Annual Zebra Run Raised Support, Funds, and Awareness for Multiple Sulfatase Deficiency (MSD) 

  Six years ago, the United MSD Foundation began its annual Zebra Run with a goal of raising multiple sulfatase deficiency (MSD) awareness, as well as garnering funds to advance…

Continue Reading 6th Annual Zebra Run Raised Support, Funds, and Awareness for Multiple Sulfatase Deficiency (MSD) 
Now Approved: Skyclarys for Friedreich Ataxia
Source: https://unsplash.com/photos/ZHys6xN7sUE

Now Approved: Skyclarys for Friedreich Ataxia

  Until recently, the only therapeutic options for people with Friedreich ataxia were symptomatic and focused on symptom management: mobility aids, surgery, psychotherapy, speech therapy, heart medications, hearing and vision…

Continue Reading Now Approved: Skyclarys for Friedreich Ataxia
European Commission Approves First-Ever Gene Therapy for Adult Hemophilia B Patients
source: unsplash.com

European Commission Approves First-Ever Gene Therapy for Adult Hemophilia B Patients

According to a story from Globe Newswire, the gene therapy company uniQure recently announced that it has received conditional marketing authorization for its gene therapy etranacogene dezaparvovec (marketed as HEMGENIX®).…

Continue Reading European Commission Approves First-Ever Gene Therapy for Adult Hemophilia B Patients
Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer
source: pixabay.com

Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer

  Researchers have been grappling for years with the STAT5 protein as a tool to fight cancer. STAT5 is critical because it is partly responsible for the development and progression…

Continue Reading Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer
Being an Olympic Swimming Legend Doesn’t Ease the Burden of Chronic Inflammatory Demyelinating Polyneuropathy
source: pixabay.com

Being an Olympic Swimming Legend Doesn’t Ease the Burden of Chronic Inflammatory Demyelinating Polyneuropathy

  After winning the 1998 100m butterfly in Perth, breaking a world record, winning 54 international medals, and becoming the Swimming Hall of Fame inductee in 2022, Michael Klim appeared…

Continue Reading Being an Olympic Swimming Legend Doesn’t Ease the Burden of Chronic Inflammatory Demyelinating Polyneuropathy
Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories
source: pixabay.com

Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories

  The failure rate of drug development for Alzheimer’s is 99 percent according to a recent study. Since 1984 scientists have concentrated on developing treatments to prevent the formation of…

Continue Reading Alzheimer’s Disease: An Influential 2006 Study Containing False Images Leads Scientists To Reverse Previous Theories
Foundation for Angelman Syndrome Therapeutics Enters Partnership with Rush University for Research Center
source: unsplash.com

Foundation for Angelman Syndrome Therapeutics Enters Partnership with Rush University for Research Center

  The Foundation for Angelman Syndrome Therapeutics (FAST) recently entered a partnership with Rush University in order to establish a clinical trial and translational research center for rare neurodevelopmental disorders.…

Continue Reading Foundation for Angelman Syndrome Therapeutics Enters Partnership with Rush University for Research Center